It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

pharmaceuticals

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Japan approves dexamethasone as second drug for coronavirus treatment

National / Science & Health Jul 22, 2020

Japan approves dexamethasone as second drug for coronavirus treatment

The inexpensive and easy-to-obtain drug is used to treat a wide range of conditions including lung disease.

Wave of promising study results raise hopes for coronavirus vaccines

World / Science & Health Jul 21, 2020

Wave of promising study results raise hopes for coronavirus vaccines

Early data from trials of three potential COVID-19 vaccines released on Monday, including a closely watched candidate from Oxford University, increased confidence that a vaccine can train the immune system to recognize and fight the novel coronavirus without serious side effects. Whether any of these ...

Fujifilm to start another Avigan study in Kuwait following setback in Japan

National / Science & Health Jul 18, 2020

Fujifilm to start another Avigan study in Kuwait following setback in Japan

The trial is to be conducted with India's Dr. Reddy's Laboratories and will involve up to 1,000 people to assess the flu drug's effectiveness against the coronavirus.

Japan in talks with Johnson & Johnson to secure COVID-19 vaccine

Business / Corporate Jul 17, 2020

Japan in talks with Johnson & Johnson to secure COVID-19 vaccine

The company has already agreed to prioritize an allocation to the United States as part of a funding agreement, according to the firm's chief financial officer.

Coronavirus cold war flares up with claims of Russian vaccine hack

World | FOCUS Jul 17, 2020

Coronavirus cold war flares up with claims of Russian vaccine hack

The international race for protection from the virus escalated to a new level with allegations that vaccine development has become a target of Russian cyberattacks.

Japan and Germany agree to cooperate over COVID-19 vaccine development

National Jul 17, 2020

Japan and Germany agree to cooperate over COVID-19 vaccine development

Abe told Merkel that his country will contribute to the development and distribution of vaccines through the WHO's ACT-Accelerator.

Pfizer and BioNTech coronavirus vaccine candidates on FDA fast track

Business / Corporate Jul 14, 2020

Pfizer and BioNTech coronavirus vaccine candidates on FDA fast track

The U.S.-listed shares of the German firm climbed about 15 percent, while Pfizer's stock rose about 5 percent.

Avigan's effectiveness inconclusive in Japan COVID-19 trial

National / Science & Health Jul 10, 2020

Avigan's effectiveness inconclusive in Japan COVID-19 trial

Promoted heavily by Prime Minister Shinzo Abe, the flu drug did not yield any statistically significant results after administered to 89 patients across Japan.

The fight over a coronavirus vaccine will get ugly

Commentary / World Jul 8, 2020

The fight over a coronavirus vaccine will get ugly

by Andreas Kluth

Once COVID-19 shots become available, there will be arguments about who gets them, and an even bigger battle with anti-vaxxers who refuse them.

Moderna spars with U.S. scientists over COVID-19 vaccine trials

World / Science & Health Jul 7, 2020

Moderna spars with U.S. scientists over COVID-19 vaccine trials

As the United States accelerates the search for a coronavirus vaccine, tensions have erupted between government scientists and Moderna Inc., one of the leading developers, it has been learned. The federal government is supporting Moderna’s vaccine project with nearly half a billion dollars and has ...

Takeda considers sale of OTC drug unit to focus on profitable products

Business / Corporate Jul 6, 2020

Takeda considers sale of OTC drug unit to focus on profitable products

Takeda Pharmaceutical Co. is considering selling its over-the-counter medicine unit for around ¥400 billion ($3.7 billion) to focus on developing cancer treatments and other advanced medical-use drugs that can generate higher profitability, a source said Monday. The envisioned sale of Takeda Consumer Healthcare Co. comes ...

How Moderna execs are cashing in during the race to develop COVID-19 vaccine

Business Jul 3, 2020

How Moderna execs are cashing in during the race to develop COVID-19 vaccine

by Tom Bergin and Robin Respaut

Biotech firm Moderna Inc. could reap tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If it loses, the early-stage company’s value could crash. In the meantime, the firm’s chief executive is pocketing millions of ...

« 1 … 31 32 33 … 42 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times